IL6 and COVID-19: Therefore, a reduced-innate antiviral defense coupled with exaggerated inflammatory IL-6 production might be responsible for SARS-CoV2 airway infection and dissemination as well as for the cytokine storm associated to worse progression in COVID-19 patients [51].